Recipharm has appointed a new business director for the Italian pharmaceutical market and a new general manager at Pessac, France.
Franco Boselli joins the business management team as business director in Italy with the main task to sell Recipharm’s full service offering to Italian pharmaceutical companies. He reports to the vice president of business management Kenth Berg, and is based in Milan.
Prior to joining Recipharm, Boselli worked in marketing and sales in different pharmaceutical companies in Italy. In 2009, he joined the B2B business as business development manager in Mipharm, the Italian CMO specializing in non-sterile products. In 2011, he joined Biologici Italia Laboratories, later part of the Corvette group acquired by Recipharm last year, as business development director. In this role, he managed Corvette’s key customers and was responsible for the scouting of new business, including the out-licensing of dossiers of sterile injectables and the development of new dossiers for generic products as well as sales of contract manufacturing of lyophilised and sterile formulations.
Bernard Pluta joins Recipharm as general manager for the operating company in Pessac, France and will report to the executive vice president of development and technology, Carl-Johan Spak. Pluta has had a long career in the pharma industry, having held executive positions in Theramex and Teva. He currently runs his own CMO consultancy business. Pluta’s primary task is to drive the performance at the company through the sales of new projects and operational excellence. He commenced his role on Oct. 19, replacing Stéphane Guisado who will continue in his role as general manager in Recipharm Fontaine.